Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
her face was paralyzed for almost a year; This serious case was reported by a consumer via interactive digital media and described the occurrence of facial paralysis in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced facial paralysis (Verbatim: her face was paralyzed for almost a year) (serious criteria GSK medically significant and other: Serious as per reporter). The outcome of the facial paralysis was resolved. The reporter considered the facial paralysis to be related to Shingrix. The company considered the facial paralysis to be unrelated to Shingrix. Additional Information: GSK receipt date: 09-MAR-2025 This case was reported by a patient's sister via interactive digital media. The patient got it (Shingrix) and her face was paralyzed for almost a year.; Sender's Comments: Facial paralysis is an unlisted event which is considered unrelated to GSK vaccine Shingrix.